Immunotherapy for lung cancer: for whom the bell tolls?

Immunotherapy for lung cancer: for whom the bell tolls?

Item
http://www.wikidata.org/entity/Q38367414
The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis.Profiling cancer testis antigens in non-small-cell lung cancer.Potential role of immunotherapy in advanced non-small-cell lung cancerImmune checkpoint therapy for non-small-cell lung cancer: an update.Emerging targets for radioprotection and radiosensitization in radiotherapy.Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker.Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: Meta-analysis and systematic review.
P2860

Immunotherapy for lung cancer: for whom the bell tolls?

Item
http://www.wikidata.org/entity/Q38367414
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Immunotherapy for lung cancer: for whom the bell tolls?
@en
type
label
Immunotherapy for lung cancer: for whom the bell tolls?
@en
prefLabel
Immunotherapy for lung cancer: for whom the bell tolls?
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Immunotherapy for lung cancer: for whom the bell tolls?
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921